Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 321
Selected: 0
NCT IDTitle
NCT04354987Compare the Pharmacokinetics and Safety of CKD-391
NCT04224350Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)
NCT01426100CKD-828 Telmisartan Non-Responder Trial
NCT03920579A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
NCT03209180Immediate Release Versus Slow Release Carvedilol in Heart Failure
NCT01630018Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
NCT01819870Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
NCT04660370A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
NCT04703374A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT02005757Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
NCT02356679Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
NCT03414840Assessment of Change in Atherosclerotic Plaque by Serial CCTA
NCT04478097Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT02159976Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
NCT01016626Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet
NCT07304726Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
NCT05698043A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
NCT05540912Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects
NCT04312698Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
NCT01128322CKD-828 Primary Hypertension Trial(Dose-selection)
NCT01501253CKD-828 S-Amlodipine Non-Responder Trial
NCT01684605Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers
NCT03428594CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis
NCT05274880Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
NCT03868072Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
NCT07365358Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
NCT03558425A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT02494284Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
NCT07215637Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
NCT01560325Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT03233932CKD-841 Pharmacokinetic/Pharmacodynamic Study
NCT03062059The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
NCT04083846Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT03858725Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
NCT01369472Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
NCT02526875Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
NCT02451098Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
NCT06838286Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
NCT06627322A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
NCT03246880Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT01071720The Effect of Food on the Pharmacokinetic Characteristics of CKD-501
NCT04019743Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
NCT01983735Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
NCT01005160Drug Interaction Between CKD-501 and Metformin
NCT02565368A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
NCT02484482Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
NCT02002611Drug-drug Interaction Study(Lobeglitazone, Warfarin)
NCT05677438A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
NCT05634447A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391